ARTICLE | Company News
Pharmaxis seeking Australian approval of Bronchitol
October 2, 2008 1:17 AM UTC
Pharmaxis (ASX:PXS; NASDAQ:PXSL) submitted a marketing application to Australia's Therapeutic Goods Administration (TGA) for Bronchitol to treat bronchiectasis. The formulation of mannitol in a dry po...